Skip to main content
SRTS
NASDAQ Industrial Applications And Services

Sensus Healthcare Secures New $15M Revolving Credit Facility to Address Liquidity Concerns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$2.7
Mkt Cap
$44.448M
52W Low
$2.66
52W High
$5.92
52W Position info
1.5% above low
Off High info
54% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SRTS is trading near its 52-week low of $2.66 (1.5% above the low).

Summary

Sensus Healthcare has secured a new $15 million revolving credit facility with City National Bank of Florida, replacing its previously terminated credit line and providing crucial working capital.


Key Events · Financing and Capital Events · SRTS

  • New $15 Million Revolving Credit Facility

    Sensus Healthcare, Inc. entered into a Loan Agreement with City National Bank of Florida for a revolving credit facility providing maximum borrowings of $15,000,000.

  • Replaces Terminated Credit Line

    This new facility replaces the company's previous revolving credit facility with Fifth Third Bank, N.A., which had been terminated.

  • Secured by Company Assets and Cash Collateral

    The loan is secured by a first priority security interest in all of the company's assets and $2,230,000 in cash collateral.

  • Restrictive Covenants and Maturity

    The facility has a maturity date of June 5, 2027, and includes financial covenants such as a minimum debt service coverage ratio of 1.50, along with restrictions on asset sales, incurring other debt, or removing key officers without bank consent.


Analysis · SRTS · Industrial Applications And Services

Sensus Healthcare, which recently reported a significant revenue decline and increased net loss for Q1 2026, was facing heightened liquidity concerns due to the termination of its previous $15 million credit facility. This new $15 million revolving credit facility, secured with City National Bank of Florida, directly addresses that critical funding gap. While the loan comes with restrictive covenants, including a minimum debt service coverage ratio and limitations on asset sales and executive changes, it provides essential working capital and extends the company's financial runway until June 2027. This is a crucial development for the company's operational continuity, especially as it trades near its 52-week low.

At the time of this filing, SRTS was trading at $2.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $44.4M. The 52-week trading range was $2.66 to $5.92. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SRTS - Latest Insights

SRTS
Jun 05, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $3.10 info
Change: +$0.400 (+15%) info
Market Cap: $51.032M info
SRTS
May 13, 2026, 2:48 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.49
Real-time Price: $3.10 info
Change: -$0.385 (-11%) info
Market Cap: $51.032M info
SRTS
May 08, 2026, 1:55 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.14
Real-time Price: $3.10 info
Change: -$0.035 (-1%) info
Market Cap: $51.032M info
SRTS
May 07, 2026, 4:31 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $3.86
Real-time Price: $3.10 info
Change: -$0.760 (-20%) info
Market Cap: $51.032M info
SRTS
May 07, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.86
Real-time Price: $3.10 info
Change: -$0.760 (-20%) info
Market Cap: $51.032M info